Genetics at the Supreme Court 1: patenting genes

In a unanimous 9-0 decision, the US Supreme Court has ruled that human genes cannot be patented. The implication of this important case, Association for Molecular Pathology v. Myriad Genetics, is that genetic tests may become much cheaper. Myriad held patents on the BRCA1 and BRCA2 genes, which are associated with breast and ovarian cancer. Its tests, which cost about US$3,000, were far too expensive for many women. Some observers have optimistically declared that the price could sink to $100.

Thousands of genes have been patented over the past 30 years, so the decision could open up new avenues for tests, medicine and genetic research.

“Myriad did not create anything,” Justice Clarence Thomas wrote in the decision. “To be sure, it found an important and useful gene, but separating that gene from its surrounding genetic material is not an act of invention.”

The court’s decision did not come as a surprise and Myriad’s share price actually rose briefly, before falling by about 5%. The court upheld its claims on complementary DNA. 

This article is published by Xavier Symons and BioEdge.org under a Creative Commons licence. You may republish it or translate it free of charge with attribution for non-commercial purposes following these guidelines. If you teach at a university we ask that your department make a donation. Commercial media must contact us for permission and fees. Some articles on this site are published under different terms.

comments powered by Disqus

 Search BioEdge

 Subscribe to BioEdge newsletter
rss Subscribe to BioEdge RSS feed

 Recent Posts
Should governments overrule parents who oppose transgender puberty-blockers? Yes, says bioethicist
24 Feb 2019
Young blood is probably snake oil, says FDA
24 Feb 2019
Leading Irish hospital makes willingness to do abortions a condition of employment
24 Feb 2019
Wife who travelled with husband to Dignitas will not be disinherited
24 Feb 2019
Should fat stigma be banned?
24 Feb 2019

Home | About Us | Contact Us | rss RSS | Archive | Bookmark and Share | michael@bioedge.org

BioEdge - New Media Foundation Ltd © 2004 - 2009 All rights reserved -- Powered by Encyclomedia